Broker Recommendations
Credit Suisse ups Persimmon price target and reinstates dividend target
Credit Suisse upped its price target on Persimmon and reinstated its dividend target after the housebuilder's positive trading statement.
Liberum hits Codemasters with 'buy' rating
Analysts at Liberum reiterated their 'buy' rating on video games developer Codemasters on Friday, stating the group was "ready to wow".
Peel Hunt lifts Avast price target on higher revenue expectations
Peel Hunt upped its price target on cybersecurity company Avast to 355p from 322p on Friday, citing higher revenue expectations as people spend more time on their computers due to the Covid-19 pandemic.
Canaccord Genuity hikes target price on Persimmon
Analysts at Canaccord Genuity hiked their target price on housebuilder Persimmon from 2,360. 0p to 2,700. 0p on Friday, stating the group was now outperforming after a "swift" return to work.
Berenberg raises target price on Smith & Nephew
Analysts at Berenberg slightly lowered their target price on medical equipment manufacturer Smith & Nephew from £21. 65 to £21. 50 on Friday, stating Covid-19 had raised questions regarding the group's future.
Citi downgrades Vistry, sees better value elsewhere
Citi downgraded its stance on shares of Vistry to ‘neutral’ from ‘buy’ on Friday as it tweaked its estimates to reflect "a slower fixed cost absorption on the back of the Covid-19 disruption".
Thursday broker round-up
Hargreaves Lansdown: Berenberg reiterates hold with a target price of 1,830. 0p.
Liberum lowers target price on Non-Standard Finance
Analysts at Liberum slashed their target price on home credit provider Non-Standard Finance from 47p to 24. 3p on Thursday but stood by their 'buy' rating on the group.
Berenberg raises target price on Hargreaves Lansdown
Analysts at Berenberg hiked their target price on asset manager Hargreaves Lansdown from 1,705p to 1,830p on Thursday, stating the firm had experienced a "step-change in customer growth" during the UK's Covid-19 lockdown.
Peel Hunt says Vor Biopharma cash call validates Puretech Health's model
Analysts at Peel Hunt reiterated their 'Conviction Buy' recommendation for shares of PureTech Health following a $110. 0m funding round for its founded entity Vor Biopharma, arguing that the transaction validated its business model.
Berenberg hikes target price on Hill & Smith
Analysts at Berenberg hiked their target price on construction products supplier Hill & Smith from 1,325. 0p to 1,420. 0p on Wednesday, stating the group offered investors three "attractive characteristics".
Wednesday broker round-up
Persimmon: Peel Hunt upgrades to add with a target price of 2,730. 0p.
RBC Capital upgrades Rio Tinto, highlights attractive dividend yield
RBC Capital Markets upgraded its stance on shares of miner Rio Tinto to ‘sector perform’ from ‘underperform’ on Wednesday, hiking the price target to 4,200p from 3,600p.
WPP slumps as Credit Suisse reinstates coverage at 'underperform'
WPP slumped on Wednesday after Credit Suisse reinstated coverage of shares in the advertising company at ‘underperform’ with a 565p price target, pointing to "rising industry disruption".
Shore Capital says sell Boohoo on supply-chain issues
Shore Capital downgraded Boohoo to 'sell' and said the company's share price did not reflect the risks created by allegations of mistreatment of workers in its supply chain.
Morgan Stanley upgrades Hikma to 'overweight'
Morgan Stanley upgraded Hikma Pharmaceuticals to 'overweight' and upped its price target on the company's shares because the market is undervaluing the launch of two drugs.
Deutsche raises GVC price target, predicts positive trading update
Deutsche Bank raised its price target for GVC shares and said the gambling company's trading statement on 16 July should bring positive news.
Berenberg hikes target price on Standard Life Aberdeen
Analysts at Berenberg raised their target price on global investment company Standard Life Aberdeen from 190. 0p to 275. 0p on Tuesday, stating that recent management changes held the potential to drive a "change in strategy".
Canaccord hikes target for Intermediate Capital Group, spies bottom in fund flows
Analysts at Canaccord Genuity hiked their target price for shares of Intermediate Capital Group, arguing that investors' focus on losses on the Investment Co. side of the business.